Location History:
- Framingham, MA (US) (2017)
- Waltham, MA (US) (2022)
Company Filing History:
Years Active: 2017-2025
Title: The Innovative Contributions of Anna M Potier
Introduction
Anna M Potier is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of health sciences, particularly in the area of sample preparation from dried blood. With a total of 3 patents to her name, her work has the potential to enhance diagnostic processes and improve patient outcomes.
Latest Patents
Among her latest patents is a groundbreaking method for sequentially preparing different test samples from a single dried blood sample. This innovative process allows for the preparation of test samples that include targets of differing structures. Specifically, it enables the same dried blood sample to be used for the preparation of a first test sample that includes a non-nucleic acid target. Subsequently, the same sample can be processed to prepare a test sample that includes a nucleic acid target. This method preserves the ability of the nucleic acid to be detected in subsequent detection assays, even after the prior isolation of non-nucleic acid targets.
Career Highlights
Anna has worked with prominent companies in the health sciences sector, including PerkinElmer Health Sciences, Inc. and Revvity Health Sciences, Inc. Her experience in these organizations has allowed her to develop and refine her innovative techniques, contributing to advancements in medical diagnostics.
Collaborations
Throughout her career, Anna has collaborated with talented individuals such as Stephanie Dallaire and Jordan Haddock. These partnerships have fostered a creative environment that encourages the development of new ideas and solutions in health sciences.
Conclusion
Anna M Potier's contributions to the field of health sciences through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in diagnostic methods, ultimately benefiting the healthcare industry.